ArticleMedicine and pharmacy reports2025
Associations between fetal biometric para-meters and maternal characteristics in the prenatal screening phase for aneuploidies.
Article in Medicine and pharmacy reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: Aneuploidies are rare diseases with great impact on an individual's life, as well as on their families, the reason why prenatal screening is performed, allowing families to take an informed decision. Initial prenatal screening includes the double test, triple test, non-invasive prenatal testing and ultrasonography. Among these, ultrasonography plays an important role giving information regarding an elevated risk for aneuploidies. Methods: Eighty-four pregnant women who underwent prenatal screening were included in this study, of whom 9 cases were diagnosed with an aneuploidy. A statistical analysis was performed to identify possible associations between morpho-fetal characteristics, estimated fetal growth, and other parameters, such as maternal characteristics or gestational age. Results: As expected, based on the data available in the literature, an advanced maternal age was observed in the high-risk group, compared to the low-risk one (the risk was evaluated after the initial screening and influenced the decision of a further amniocentesis). A good correlation was observed in this study between the fetal biometric parameters and gestational age, as well as between fetal biometric parameters and maternal weight gain in healthy pregnancies, while low or no correlations were found in the aneuploid pregnancies. Conclusions: The results of our study highlight the importance of ultrasonography evaluation and reveal possible correlations of fetal parameters with maternal characteristics. These findings, together with already well-established parameters, might suggest stronger clusters of soft markers and bring supplementary information regarding the risk level of pregnancy, in order to perform a better assessment of cases where invasive diagnosis is required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.